Blockade of interleukin 1 receptor in still's disease affects activation of peripheral T-lymphocytes

Journal of Rheumatology

Volumn 35, Issue 12, 2008, Pages 2453-2456

  Youssef, Jihad ^a   Lazaro, Estibaliz ^a   Blanco, Patrick ^a   Viallard, Jean François ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; FERRITIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; LIVER ENZYME; METHOTREXATE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; THALIDOMIDE;

ADULT; ADULT ONSET STILL DISEASE; CASE REPORT; DISEASE ACTIVITY; DRUG DOSE REDUCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LETTER; LEUKOCYTE COUNT; NEUTROPHIL; PANCYTOPENIA; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIRHEUMATIC AGENTS; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; PREDNISONE; STILL'S DISEASE, ADULT-ONSET; T-LYMPHOCYTE SUBSETS;

EID: 57349101775     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080203     Document Type: Letter

References (12)

1. Bywaters EG. Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.
2. Chen DY, Lan JL, Lin FJ, et al. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis 2004;63:1300-6.
3. Lequerre T, Vittecoq O, Le Loët X. What is the role for interleukin-1 receptor antagonist in rheumatic disease. Joint Bone Spine 2007;74:223-6.
4. Lequerre T, Quartier P, Rosellini D, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still's disease: Preliminary experience in France. Ann Rheum Dis 2008;67:302-8.
5. Yamaguchi M, Ohta A, Tsunematsu, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-35.
6. Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005;201:1355-9.
7. Vasques Godinho FM, Parreira Santos MJ, Canas da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005;64:647-8.
8. Haraoui B, Bourrelle D, Kaminska E. Anakinra in the treatment of adult onset Still's disease [abstract]. Ann Rheum Dis 2004;63 Suppl 1:263.
9. Fitzgerald AA, Leclercq SA, Yan A, et al. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 2005;52:1794-803.
10. Choi JH, Suh CH, Lee YM, et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 2003;30:2422-7.
11. Blanco P, Pitard V, Viallard JF, et al. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:201-11.
12. Koeller M, Kiener H, Simonitsch I, et al. Destructive lymphadenopathy and T-lymphocyte activation in adult-onset Still's disease. Br J Rheumatol 1995;34:984-8.